Market Closed

HIND
Vyome Holdings
$ 1.58
-3.07%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

Vyome Holdings News

Latest Vyome Holdings Stock News & HIND Headlines

Vyome Appoints Experienced Public Company Finance Executive Jerry Leonard as Chief Financial Officer
2 months ago | businesswire.com
Vyome Granted Chinese Patent Strengthening Immuno-Inflammation Portfolio
4 months ago | businesswire.com
Vyome Holdings Reports First Quarter 2026 Results With Key FDA Filings and Strong Balance Sheet
6 months ago | gurufocus.com
Vyome Holdings Reports First Quarter 2026 Results With Key FDA Filings and Strong Balance Sheet
6 months ago | businesswire.com
Vyome Strikes Deal With Impetis Biosciences, Opening A ~$57B Market Opportunity
6 months ago | businesswire.com
Vyome Presents Transformational VT-1953 Phase 2 Clinical Study Data at Prestigious AACR 2026
7 months ago | businesswire.com
Vyome to Present Compelling Phase 2 Clinical Data on VT-1953 for Treatment of MFW at AACR 2026
7 months ago | businesswire.com
Vyome Reports Transformational 2025 Results: Company Well Positioned for Breakout Phase
8 months ago | businesswire.com
Vyome Announces the Publication of Positive Preclinical Results in Uveitis, Addressing a $3B Potential Market Opportunity
9 months ago | businesswire.com
Vyome Files for VT-1953 Orphan Drug Status, Furthers Strategic Focus On VT-1953 Program Over the Next 6 Months
9 months ago | businesswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

HIND
Vyome Holdings
$ 1.58
-3.07%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago